Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF



GREY:IPHAF - Post by User

Bullboard Posts
Post by biodelatechon Aug 18, 2005 4:47pm
252 Views
Post# 9430476

no partnering may be better for now

no partnering may be better for nowmany longs are yearning for a partner for psoriasis I´m not. granted, to sell 247 with with an own sales force may be to expensive. I think the best way is to wait until , hopefully stellar, phase 3 results are out and then the pick a distribution partner for each region. most biotechs partner before phase 3 is even started. so they end up with a rather weeny percentage of the profit. ISA will get a much better deal if it enters serious talks after a finished sucessful phase 3 trial.
Bullboard Posts